2026 Cleveland DSO Market Trends & Buyer Activity Explained

Key Takeaways

• Cleveland DSO activity remains elevated in 2026, with multiple national and regional buyers acquiring practices in Northeast Ohio.

• Valuation multiples vary by practice size, specialty status, and EBITDA quality signals such as associate depth and hygiene revenue share.

• Labor shortages, especially among hygienists, are compressing EBITDA and prompting buyers to scrutinize staffing stability during diligence.

• Specialty and multi-site practices attract the strongest demand and highest multiples in the current Cleveland market.

• McLerran & Associates helps Northeast Ohio practice owners compare DSO and private-buyer options with a structured process that surfaces competitive offers. Explore a confidential discovery conversation to learn what your practice may be worth.

Five Key 2026 Cleveland DSO Trends

The table below highlights five notable shifts in Cleveland’s 2026 DSO market and explains how each trend can affect a potential sale.

Trend	What Is Happening	Cleveland/Ohio Signal	Sell-Side Implication
Shift toward de novo and organic growth	Several DSOs are prioritizing de novo openings alongside acquisitions in 2026	MB2 Dental opened a de novo orthodontic practice in Ohio in 2026. Heartland Dental did not open any de novo practices in Ohio in June 2026; its June de novo openings were in North Carolina, South Carolina, and Florida	Premium existing practices face less competition from new-build supply. Well-run practices with durable EBITDA can be some of the main factors that remain selective acquisition targets.
Active multi-DSO buyer presence	Ohio recorded multiple DSO affiliations, openings, and acquisitions in Q1 2026 alone	Premier Care Dental Management, Smile Partners USA, Phase 1 Equity, Specialty1 Partners, and Seva Dental recorded Ohio activity in early 2026.	Multiple active buyers can create competitive tension that pushes valuations higher, but only when a structured process brings all of them to the table.
Labor shortage compressing EBITDA	Among dentists actively recruiting or who had recently recruited a dental hygienist, 91% reported very or extremely challenging conditions, according to the ADA Health Policy Institute in April 2026.	Cleveland hygienists earn competitive wages, with temp and per diem rates reaching $60+ for same-day coverage.	Labor costs have become a key diligence focus. Practices with stable, tenured hygiene teams can support stronger multiples.
Valuation multiples tiered by size and quality	2026 DSO acquisition multiples range from 5x–8x EBITDA for single-location practices to 10x–14x+ for specialty practices	EBITDA quality signals such as associate depth, hygiene revenue share, and payer mix can determine where a practice lands within its band.	Clear, well-supported EBITDA positioning before going to market can shift a practice meaningfully within its valuation range.
Specialty and multi-site demand intensifying	Specialty1 Partners entered a joint venture with a periodontics practice in greater Cleveland in 2026.	Phase 1 Equity added a multi-site orthodontic practice in Ohio, and specialty acquisitions are outpacing general-practice deal volume in the state.	Specialty and multi-site owners in Northeast Ohio operate in a high-demand segment with a limited supply of premium targets.

Cleveland’s 2026 Dental Market Landscape

Ohio’s dental market is mature and highly competitive. The state is home to approximately 5,800 active dentists and is served by national platforms such as Aspen Dental, Heartland Dental, Mortenson Dental Partners, Great Expressions Dental Centers, Smile Brands, and North American Dental Group. Within that environment, Northeast Ohio, particularly the Cleveland-Akron corridor, receives significant DSO acquisition attention due to its established patient base and infrastructure, with Cuyahoga County showing the highest dentist concentration in the state.

The first half of 2026 produced a steady flow of transactions. Seva Dental expanded in Northeast Ohio with partner practices. Premier Care Dental Management acquired Toledo Periodontics in March 2026, adding to a series of Ohio closings that began in January. Broader Cleveland M&A activity across sectors also showed positive momentum in 2026, even as national deal volume declined, which suggests that the local market is absorbing capital at an above-average rate.

For sellers, Northeast Ohio currently functions as one of the more active regional dental M&A markets in the country. Justin Klingshim, who leads McLerran & Associates’ Cleveland office, works directly in this market with recent Ohio closings. The firm’s sell-side process is designed to surface every qualified buyer in this environment, not just the one or two that reach out directly, and to create the competitive tension that can move a transaction from a single offer to a market-clearing outcome.

Valuation Benchmarks and EBITDA Quality Signals

EBITDA, or earnings before interest, taxes, depreciation, and amortization, is the primary metric DSO and private equity buyers use to value dental practices. It reflects the cash-generating capacity of the business after normalizing for owner compensation and one-time expenses. The multiple applied to EBITDA then determines enterprise value.

In 2026, Cleveland-area general dental practices typically see valuation ranges that mirror national benchmarks, with adjustments for local buyer competition. Single-doctor general practices often transact at 5x–8x EBITDA, multi-doctor or multi-location groups at 7x–10x, and specialty practices at 10x–14x+ in 2026 DSO transactions. For private, doctor-to-doctor sales, general dental practices commonly trade at 65–85% of annual gross collections, a method that focuses on goodwill and revenue transferability rather than profitability alone.

The spread between the bottom and top of any valuation band can be significant and can reach hundreds of thousands or even millions of dollars. Several quality signals can move a practice toward the upper end of its range:

• Associate depth: Adding even one producing associate can move an owner-dependent practice up approximately one full turn of EBITDA by reducing key-person risk.

• Hygiene revenue share: A hygiene base above 28–33% of collections can support premium multiples by signaling stable, recurring revenue.

• Payer mix: A commercial-weighted payer mix above 50% can support the higher end of valuation multiples, while heavy Medicaid reliance can compress them.

• Owner production concentration: Practices where the owner performs 90% or more of production may see valuation reductions of roughly 10–20%.

• Patient retention: Active hygiene patient retention above 75% can lift multiples, while retention below 60% can raise buyer concerns about long-term revenue durability.

• EBITDA margin: An EBITDA margin of 20% or higher is often associated with stronger valuation outcomes.

As the data above suggests, current multiples reflect a recalibration from the 2021–2023 peak, with buyers now scrutinizing trailing-twelve-month EBITDA more closely. Dental practice sale velocity slowed in 2024–2025 as interest rates rose, and buyers in 2026 are paying closer attention to recent EBITDA trends. For sellers, EBITDA quality, not just top-line revenue, can be some of the main factors in buyer negotiations.

Request a complimentary EBITDA analysis from McLerran & Associates, a CPA-led, diligence-grade review that helps control the narrative around your practice’s value before any buyer does.

Labor Shortage Realities and Retention Tactics

One of the most significant factors compressing EBITDA in Cleveland practices, and therefore affecting the multiples discussed above, is the structural dental hygiene labor shortage. The ADA’s April 2026 survey, which showed that 91% of dentists found hygienist recruitment very or extremely challenging, reflects an ongoing condition rather than a short-term disruption, and only 60% of dentists reported having an adequate number of hygienists on staff.

In Cleveland, the financial impact of this shortage is clear. As noted earlier, temp coverage in Cleveland can cost $60 or more per shift, and that rate compounds quickly when hygiene turnover is high. A single hygienist often produces $1,200–$2,000 per day, so an empty hygiene column can cost thousands in lost production per week.

Several structural drivers sit behind these numbers. The American Dental Hygienists’ Association’s May 2026 position statement described a shortage of workplaces worth staying in, driven by organizational conditions rather than a lack of qualified professionals. GoTu’s 2026 State of Work Report, developed with the ADHA, found that burnout affects 54.1% of all dental professionals and 60.6% of hygienists, with workload and office culture as leading causes.

Cleveland practices that have stabilized their hygiene teams often rely on a mix of practical steps:

• Raising base pay bands to reflect current market rates

• Offering flexible scheduling, including four-day workweeks and shorter shifts

• Using temp coverage strategically rather than as a constant backstop

• Cross-training assistants and front-desk staff to support hygiene workflows

• Investing in onboarding and professional development to reduce turnover

For sellers, DSO buyers now view hygiene staffing stability as a proxy for revenue durability. A practice with a tenured, full hygiene team and documented retention systems presents a lower integration risk than one that depends heavily on temp coverage. That difference can move a practice within its valuation band and, in some cases, can influence whether a buyer proceeds at all.

Specialty Demand and Multi-Site Advantages

Specialty dental practices and multi-site groups currently operate in a part of the Cleveland market where buyer demand often exceeds available supply. In a 2026 survey, 69% of DSOs expected to increase acquisition activity and reported a reduced supply of premium dental practices, which creates a high-demand, low-supply environment.

In Northeast Ohio, this pattern appears clearly in recent transactions. Specialty1 Partners entered a joint venture with a periodontics practice in greater Cleveland in 2026. MB2 Dental pursued de novo orthodontic openings in Ohio in 2026, which signals the density strategy national DSOs are following in the state.

Specialty practices tend to command higher valuation multiples than general dentistry across size bands, reflecting higher per-procedure margins, referral-driven revenue, and stronger buyer competition. Single-specialty and multi-specialty groups often achieve materially higher EBITDA multiples than general-only practices in 2026. General practices that have added in-house specialty services such as implants, aligners, endodontics, or periodontics may qualify for a higher valuation classification than a pure general practice.

For sellers, specialty and multi-site owners in Northeast Ohio sit among the most sought-after targets in the current market. A structured sell-side process that reaches all relevant specialty DSO buyers, not just generalist platforms, can produce meaningfully different outcomes. McLerran & Associates’ dental-only focus allows the firm to track buyer demand by specialty rather than treating every practice the same.

Independent Sale Paths and Competitive Context

Not every Northeast Ohio practice owner will pursue a DSO affiliation, and not every DSO deal will fit an owner’s goals. The private, doctor-to-doctor sale remains a viable and sometimes preferable path for practices in the $1M–$1.5M revenue range, where individual buyers using SBA financing are active and where the seller’s priorities, such as legacy, staff continuity, and patient relationships, may align more closely with a single-doctor successor.

A Q2 2026 national buy-side survey reported that 69% of DSOs expect moderate-to-high increases in deal volume and cited a shortage of premium practices rather than a lack of capital. That supply constraint can benefit well-prepared sellers, but it also means buyers are applying greater scrutiny to the practices they pursue. Over-reliance on a single producer and declining trailing-twelve-month EBITDA were leading reasons buyers walked from deals in 2025.

Independent and hybrid models, including IDSO structures and joint-venture arrangements, can offer some owners a middle path. These structures allow owners to retain meaningful clinical autonomy and equity upside while accessing DSO infrastructure and capital. The 2026 dental buyer landscape includes at least seven distinct buyer types, each with different qualification thresholds, deal structures, and suitability for regional versus national strategies.

For sellers, the right path often depends on practice size, profitability, the owner’s “why,” and the specific buyers active in the Cleveland market at the time of sale. Because McLerran & Associates works private-buyer and DSO transactions in roughly equal measure, the firm can produce a side-by-side valuation that quantifies a practice’s worth in both markets so the owner chooses with clearer information rather than a guess.

Sell-Side Implications for Cleveland Owners

The 2026 Cleveland dental market creates conditions that can favor prepared sellers. Buyer activity remains elevated, specialty and multi-site demand is strong, and the supply of premium practices appears constrained. At the same time, buyers are more selective than in 2021–2023. EBITDA quality, hygiene stability, and provider depth receive closer scrutiny, and deals that cannot withstand diligence are more likely to be re-traded or abandoned.

For a Northeast Ohio practice owner generating $1.5M or more in annual revenue, several sell-side implications stand out:

• A diligence-grade EBITDA analysis, rather than a rough estimate, forms the foundation of a defensible valuation.

• A structured, competitive process among multiple vetted buyers often produces better outcomes than a single-buyer negotiation.

• Labor stability, associate depth, and hygiene revenue share are EBITDA quality signals that can move a practice toward the top of its valuation band.

• Specialty and multi-site owners currently operate in one of the highest-demand segments of the market.

• The choice between DSO affiliation and a private sale is often strongest when based on side-by-side financial modeling across both paths, not on a single offer.

McLerran & Associates has completed roughly 2,000 practice sales and evaluated more than 10,000 practices, with a transaction rate of approximately 85–90%, compared with an industry norm closer to 35–40%. The firm’s Cleveland office, led by Justin Klingshim, brings that process to the Northeast Ohio market with direct knowledge of local buyer activity, recent Ohio closings, and the EBITDA dynamics that can shape outcomes.

Find out what your practice is worth in both markets by requesting a confidential valuation analysis from McLerran & Associates before any buyer sets the terms of the conversation.

Frequently Asked Questions

How active is the DSO buyer market in Cleveland and Northeast Ohio in 2026?

Northeast Ohio ranks among the more active DSO acquisition markets in the Midwest. The Cleveland-Akron corridor receives significant DSO attention due to its established patient demographics and infrastructure. In the first half of 2026, multiple national and regional DSOs recorded Ohio transactions, including acquisitions, de novo openings, and specialty joint ventures, with activity across general dentistry, orthodontics, periodontics, and urgent care formats. For sellers, this environment provides a genuine pool of competing buyers, but surfacing all of them typically requires a structured process rather than relying on a single inbound inquiry.

How does the hygienist shortage in Cleveland affect my practice’s valuation?

Labor costs and staffing stability now appear as standard items in DSO due diligence. Cleveland hygienists currently earn competitive wages for full-time roles, with temp and per diem rates reaching $60 or more for same-day coverage. A practice that relies heavily on temp coverage or has experienced recent hygiene turnover presents a higher integration risk in a buyer’s underwriting model, which can compress the multiple applied to EBITDA or introduce contingent deal terms such as earnouts. A practice with a tenured, full hygiene team and documented retention systems presents as a lower-risk acquisition and can support a stronger valuation. Sellers who address hygiene stability before going to market, through compensation adjustments, scheduling flexibility, and culture investment, are often better positioned to defend their EBITDA story through diligence.

Should I sell to a DSO or a private buyer in the current Cleveland market?

The appropriate path often depends on practice size, profitability, and personal goals for the transition. Practices in the $1M–$1.5M revenue range can fit a doctor-to-doctor sale well, where a qualified individual buyer may pay a strong price and preserve the practice’s legacy. Practices generating $1.5M or more in revenue, especially those with associate depth, specialty services, or multiple locations, are more likely to attract DSO interest and can benefit from the higher multiples that EBITDA-based DSO valuations can provide. Owners in the middle of that range can sometimes pursue either path, and a side-by-side financial model that quantifies value in both markets across several time horizons can help clarify the choice. McLerran & Associates works both paths in roughly equal measure and builds that comparison for each client before suggesting a direction.

What EBITDA quality signals matter most to DSO buyers evaluating Cleveland practices in 2026?

DSO buyers in 2026 tend to apply greater scrutiny to EBITDA quality than in prior years. Signals that frequently move a practice toward the top of its valuation band include associate doctor production depth, which reduces owner-dependency and key-person risk, hygiene revenue as a share of total collections, which signals recurring and transferable patient demand, commercial payer mix, with Medicaid-heavy practices often seeing multiple compression, patient retention rates, and the direction of trailing-twelve-month EBITDA. Practices where the owner performs most clinical production can face valuation reductions because buyers price in the risk of revenue loss after the transition. Addressing these signals before going to market, ideally with a 12–24 month runway, can create a meaningfully different outcome than selling the practice as-is.

How does McLerran & Associates’ process differ from working directly with a DSO or using a local broker?

A DSO that approaches a practice owner directly represents a single buyer with limited incentive to improve its offer. A local broker who knows only one or two DSOs may provide narrow market exposure and lighter financial underwriting. McLerran & Associates operates as a dental-only sell-side advisor, representing the practice owner rather than the buyer, and runs a structured, auction-like process that typically generates around 10 offers from a vetted pool of qualified buyers. The firm’s CPA-led EBITDA analysis is built to diligence-grade standards so the agreed valuation can withstand buyer review and reduce the risk of last-minute re-trades. Because McLerran works private-buyer and DSO transactions in roughly equal measure, it can provide a genuine side-by-side comparison of both paths, something a single-lane broker usually cannot offer. The firm’s transaction rate of approximately 85–90% compares with an industry norm closer to 35–40%, and clients often achieve valuations that are materially higher than they might secure negotiating alone.